SEC Form 4 · accession 0000899243-18-004334
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Lynn Ziolkowski
Officer — See Remarks
Period of report
Feb 14, 2018
Accepted (ET)
Feb 15, 2018 · 8:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $26.23 | Feb 14, 2018 | A | 66,852 | A | — | Feb 14, 2028 | Common Stock | 66,852 | 66,852 | D |
Explanation of responses
- F1The option shall vest in four equal installments beginning on February 14, 2019.
Remarks
Chief Financial Officer, Treasurer and Assistant Secretary